$IVZ

Invesco Ltd. (IVZ): Results of Operations and Financial Condition

Invesco Ltd. (IVZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ivzpressrelease2q2026.htm EX-99.1 Document Exhibit 99.1 Press Release For immediate release Invesco Reports Results for the Three Months Ended June 30, 2026 Invesco Announces Second Quarter Diluted EPS of $0.76; Adjusted Diluted EPS (1) of $0.71 Investor Relations Conta

Original reporting
Published Jul 28, 2026, 10:58 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$IVZ
Bullish
high confidence
Mentioned
$IVZ
Relevance
8/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$IVZBullishMed
01

Why it matters

Key new datapoints include record net long-term inflows ($45.1B), ending AUM ($2.5T), GAAP and adjusted EPS, operating margin expansion, and balance-sheet actions (net debt reduction and increased buybacks). These can reset near-term expectations for fee revenue durability and capital return pace.

02

Market read

Provides a fresh quarterly performance snapshot that can move valuation models for asset managers via inflow momentum, margin leverage, and capital return.

03

What to watch

The filing highlights CIP market losses and deferred compensation mark-to-market effects; traders should separate core fee earnings from investment-product volatility and non-GAAP adjustments.

Relevance 8/10Novelty 8/10Timing: today’s SEC 8-K, covering Q2 results ended June 30, 2026

Background

The document is Invesco’s SEC Form 8-K (Item 2.02) with an attached press release reporting Q2 2026 financial results and operating highlights.

Company-level read

Ticker impact

$IVZBullishHigh confidence
Context

Invesco reported Q2 2026 results with $0.76 diluted EPS, $45.1B net long-term inflows, and $2.5T ending AUM, plus margin expansion.

Expected impact

Near-term bias upward if investors reward sustained inflows and margin leverage; watch for any sensitivity to fee revenue and market-driven AUM changes.

Evidence & confidence

This is a primary-source 8-K with quantified quarterly performance, including adjusted EPS and operating margin expansion, which typically drives fund-manager valuation and sentiment.

Market effects

Fund/asset-manager peers may see read-across on ETF and index flow strength and margin leverage, but this is company-specific.

Americas, Asia Pacific, and EMEA all posted net long-term inflows, suggesting broad-based demand rather than a single-region driver.

Global AUM growth and buyback activity can influence sector positioning around rate and equity/credit mix, though the catalyst is Invesco-specific.

Counterpoint

Record inflows may not fully translate into durable earnings if mix shifts toward lower-fee products or if AUM growth is partially market-driven.

Key entities

  • Invesco Ltd.

    Asset manager reporting Q2 2026 results, inflows, AUM, margins, and buyback/net-debt changes in an SEC 8-K.

Related articles

$IVZMed

Invesco Ltd. Q2 2026 Earnings Call Summary

Invesco reported Q2 2026 record net long-term inflows of $45.1B and operating margin of 37.5%, citing 17% year-to-date net revenue growth. Management said 30+ products drove over $500M in net inflows, with QQQ contributing $130M incremental net revenue in H1. It targets high-30s operating margin, a 60% payout ratio, and notes $15M quarterly one-time platform costs.

$IVZMed

Invesco (NYSE:IVZ) Surprises With Strong Q2 CY2026

Invesco (NYSE:IVZ) reported Q2 CY2026 results that beat expectations. Revenue rose 65.3% year over year to $1.83 billion, exceeding Wall Street estimates by 37%. Non-GAAP EPS was $0.71, 7.2% above consensus. Assets under management were $2.47 trillion, up 23.4% year over year, and the stock was about $30.37 after the release.